User profiles for "author:Juan Velasco"
Juan R. VelascoUniversidad de Alcala Verified email at uah.es Cited by 2065 |
Health risk of chrysotile revisited
D Bernstein, J Dunnigan, T Hesterberg… - Critical reviews in …, 2013 - Taylor & Francis
This review provides a basis for substantiating both kinetically and pathologically the
differences between chrysotile and amphibole asbestos. Chrysotile, which is rapidly …
differences between chrysotile and amphibole asbestos. Chrysotile, which is rapidly …
Analysis and design of multiagent systems using MAS-CommonKADS
CA Iglesias, M Garijo, JC González… - Intelligent Agents IV Agent …, 1998 - Springer
This article proposes an agent-oriented methodology called MAS-CommonKADS and
develops a case study. This methodology extends the knowledge engineering methodology …
develops a case study. This methodology extends the knowledge engineering methodology …
[HTML][HTML] Immunologic causes and thrombophilia in recurrent pregnancy loss
D Alecsandru, AM Klimczak, JAG Velasco, P Pirtea… - Fertility and …, 2021 - Elsevier
Certain miscarriages result from immunologic factors, but there is no clear identification of
the precise causes of recurrent pregnancy loss (RPL). Miscarriages and RPL can arise from …
the precise causes of recurrent pregnancy loss (RPL). Miscarriages and RPL can arise from …
[HTML][HTML] Clinical factors affecting endometrial receptiveness in oocyte donation cycles
SR Soares, JAG Velasco, M Fernandez, E Bosch… - Fertility and sterility, 2008 - Elsevier
OBJECTIVE: To provide a summary of the actual knowledge about the clinical factors
affecting the oocyte recipient (other than those associated with uterine cavity abnormalities) …
affecting the oocyte recipient (other than those associated with uterine cavity abnormalities) …
[HTML][HTML] Molecular dissection of colorectal cancer in pre-clinical models identifies biomarkers predicting sensitivity to EGFR inhibitors
M Schütte, T Risch, N Abdavi-Azar, K Boehnke… - Nature …, 2017 - nature.com
Colorectal carcinoma represents a heterogeneous entity, with only a fraction of the tumours
responding to available therapies, requiring a better molecular understanding of the disease …
responding to available therapies, requiring a better molecular understanding of the disease …
Quercetin mediates the down-regulation of mutant p53 in the human breast cancer cell line MDA-MB468
MA Avila, JA Velasco, J Cansado, V Notario - Cancer research, 1994 - AACR
The effects of the bioflavonoid quercetin (3, 3′, 4′, 5, 7-pentahydroxyflavone) on the
growth and cell cycle progression of the human breast cancer cell line MDA-MB468 have …
growth and cell cycle progression of the human breast cancer cell line MDA-MB468 have …
[HTML][HTML] Increasing uterine receptivity by decreasing estradiol levels during the preimplantation period in high responders with the use of a follicle-stimulating hormone …
C Simón, JJG Velasco, D Valbuena, JA Peinado… - Fertility and sterility, 1998 - Elsevier
Objective: To analyze the effect on uterine receptivity of a decrease in E2 levels during the
preimplantation period with the use of a step-down regimen in high responders undergoing …
preimplantation period with the use of a step-down regimen in high responders undergoing …
Process-oriented terminology management in the domain of Coastal Engineering
This article describes the theoretical premises and methodology presently being used in the
development of the PuertoTerm database on Coastal Engineering. In our project there are …
development of the PuertoTerm database on Coastal Engineering. In our project there are …
Assay establishment and validation of a high-throughput screening platform for three-dimensional patient-derived colon cancer organoid cultures
K Boehnke, PW Iversen… - Journal of …, 2016 - journals.sagepub.com
The application of patient-derived three-dimensional culture systems as disease-specific
drug sensitivity models has enormous potential to connect compound screening and clinical …
drug sensitivity models has enormous potential to connect compound screening and clinical …
Characterization of LY2228820 dimesylate, a potent and selective inhibitor of p38 MAPK with antitumor activity
RM Campbell, BD Anderson, NA Brooks… - Molecular cancer …, 2014 - AACR
Abstract p38α mitogen-activated protein kinase (MAPK) is activated in cancer cells in
response to environmental factors, oncogenic stress, radiation, and chemotherapy. p38α …
response to environmental factors, oncogenic stress, radiation, and chemotherapy. p38α …